MedPath
NMPA Approval

Ranitidine Hydrochloride Capsules

国药准字H44021789

August 12, 2019

Drug Information

盐酸雷尼替丁胶囊

胶囊剂

0.15g(按C13H22N4O3S计)

化学药品

August 12, 2019

Company Information

Applicant Company

Manufacturing Company

广东省肇庆市前沙街103号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁胶囊 - NMPA 批准文号 | MedPath